Spectrum Pharma (SPPI) Tops Q3 EPS by 25c

November 6, 2014 4:40 PM EST

Spectrum Pharma (NASDAQ: SPPI) reported Q3 EPS of $0.08, $0.25 better than the analyst estimate of ($0.17). Revenue for the quarter came in at $47.9 million versus the consensus estimate of $45 million.

For earnings history and earnings-related data on Spectrum Pharma (SPPI) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings